BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Long Term Debt 2023–2025
BridgeBio Oncology Therapeutics, Inc. annual long term debt history from 2025 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- BridgeBio Oncology Therapeutics, Inc. long term debt as of December 31, 2025: 2.2M.
- BridgeBio Oncology Therapeutics, Inc. long term debt for 2025 were 2.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Oncology Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $2 |
BridgeBio Oncology Therapeutics, Inc. Long Term Debt — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's long term debt history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.